Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1312
Selected: 0
NCT IDTitle
NCT01154920Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT02318082Study of Individual Adult and Pediatric Patient Dose-escalated Interleukin-2 Therapy for Refractory Chronic GVHD
NCT01858688A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer
NCT07220239Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
NCT00358163Trial of PTK787/ZK 222584 Plus Paclitaxel
NCT04043845ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies
NCT02592330Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft
NCT00418093Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma
NCT01614821Ibrutinib (PCI-32765) in Waldenstrom's Macroglobulinemia
NCT01560416Fulvestrant With or Without Ganetespib in HR+ Breast Cancer
NCT02036476Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma
NCT04341311Phase I Study of Marizomib + Panobinostat for Children With DIPG
NCT00003744Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery
NCT02041429Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca
NCT07467772Ph 2 Elacestrant in ER Positive Uterine Sarcomas
NCT01796405Clofarabine for Langerhans in Pedi
NCT00694603Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy
NCT04468061Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
NCT00422656Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
NCT06472869Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening
NCT02926729Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
NCT00675831Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies
NCT07516353my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
NCT02909777Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
NCT00622401Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
NCT00142181Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia
NCT03020030Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
NCT03929029Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma
NCT03319901Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
NCT00299780Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.
NCT03065062Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
NCT00948688Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas
NCT01112527PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
NCT02644382Improving Surgical Decision-making in Young Women With Breast Cancer
NCT04986579Scalp Cooling in MBC
NCT00003966Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
NCT00856180Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies
NCT04007588A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma
NCT00908960Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
NCT03899805A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
NCT07513324Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)
NCT01065662AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
NCT04115254Stereotactic Magnetic Resonance Guided Radiation Therapy
NCT03773666A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2)
NCT00136461A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
NCT03716739Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency
NCT00215501Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies
NCT02689401MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer
NCT02335671Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy
NCT01339039Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma